Company Overview of Aileron Therapeutics, Inc.
Key Executives for Aileron Therapeutics, Inc.
|Joseph A. Yanchik III, Esq.||24 Relationships||Founder, Chief Executive Officer, President and Director||52|
|Huw M. Nash Ph.D.||No Relationships||Co-Founder||--|
|Evan Lippman||No Relationships||Chief Financial Officer, Senior Vice President and Business Officer||--|
|Manuel C. Aivado M.D., Ph.D.||No Relationships||Chief Medical Officer and Senior Vice President||--|
|D. Allen Annis Ph.D.||No Relationships||Vice President of Biophysical and Analytical Technologies||--|
Aileron Therapeutics, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Scott Bancroft Kapnick||21 Relationships||HPS Investment Partners, LLC||57|
|Joseph A. Yanchik III, Esq.||24 Relationships||Aileron Therapeutics, Inc.||52|
|David G. Nathan M.D.||57 Relationships||Aileron Therapeutics, Inc.||--|
|Michael B. Kastan M.D., Ph.D.||14 Relationships||Aileron Therapeutics, Inc.||--|
|Loren D. Walensky M.D., Ph.D.||14 Relationships||Aileron Therapeutics, Inc.||--|
Aileron Therapeutics, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|There is no committee data available.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.